Cancer Degree Express, December 30, 2025: A Review of 2025‘s Milestone Advances in Cancer Therapy—Targeted Protein Degraders and Antibody-Drug Conjugates Make the List​

New research: Big step toward targeted molecular therapies for cancer

Next-Generation Targeted Therapies Reshape Precision Oncology Landscape

In the early 1980s, the development and application of antisense oligonucleotides that could specifically bind to messenger RNA (mRNA) and inhibit protein synthesis represented a groundbreaking advancement in molecular biology.

Two new studies represent a big step toward developing innovative molecular therapies capable of disrupting the uncontrollable growth of cancers at their roots.

MGC and Veritas In Silico Sign MOU for Joint Venture in the Development of RNA-Targeted Pharmaceuticals

Recent advancement in targeted therapy and role of emerging technologies to treat cancer